A novel sensory nerve stimulator to improve neuropathy in patients with diabetes

The use of low frequency transcutaneous sensory nerve stimulation to improve sensory nerve function and symptoms in people with diabetic peripheral neuropathy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12606000014550

Enrollment

220

Registered

2006-01-09

Start date

2006-02-20

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Double blind placebo randomised controlled trial of low frequency sensory electrical nerve stimulation within two different population groups over 12 weeks of treatment.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

55 Years to 75 Years

Healthy volunteers

Inclusion criteria

Group 1: Persons aged 55 to 65, with known diabetes duration of up to 5 years.Group 2: Persons aged 55 to 75, with known diabetes duration of up to 10 years.DPN diagnosed as insensate to 10g monofilament or reduced vibration below 4octals 128Hz graduated tuning fork.

Exclusion criteria

Inability to consent to the research, an above or below-knee amputation, cigarette smoking.

Outcome results